PeptidePedia The community reference

Custom peptide synthesis (revision 8)

Old revision·22:50, 5 Jan 2025·FreightFenna

This is an old revision of this page, as it stood at 22:50, 5 Jan 2025, saved by FreightFenna with the summary give the closure integrity test by name. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Custom peptide synthesis
InputA sequence and a specification
Priced byLength, scale, purity grade, modifications
Contrast withCatalogue supply of stocked compounds
Topic infobox · conventions

Custom peptide synthesis is the manufacture of a peptide to a sequence and specification supplied by the customer, as distinct from supply of a catalogue item held in stock. It is the ordinary route by which research peptides that are not commercially stocked are obtained.[1]

A custom order is defined by more than a sequence. Scale, purity grade, C-terminal functionality, any modifications such as acylation or cyclisation, salt form, and which determinations will appear on the certificate are all specification items, and a quotation that does not enumerate them is quoting for an underdetermined thing.[2]

Price scales with length, with target purity, and with the difficulty of the sequence — which is not predictable from length alone. A quotation therefore reflects an assessment of synthetic difficulty as much as a price list.[1]

What a specification should fix

[edit]
ItemWhy it matters
Sequence and modificationsDefines the molecule; ambiguity here is fatal
C-terminal formAcid or amide; set by linker choice
Purity gradeDetermines purification effort and price
Salt formTrifluoroacetate counterion or exchanged; affects Peptide content
ScaleNet peptide mass, not solid mass
Determinations on the certificateWhat will actually be reported

The distinction between net peptide mass and solid mass is the one most often left ambiguous. An order for "10 mg" may be filled as 10 mg of solid, which at typical content is rather less peptide, or as solid containing 10 mg of peptide. The two differ by the counterion and water fractions.[2]

Sequence ambiguity is the failure with the largest consequence. One-letter and three-letter codes, D-residue conventions, and non-standard abbreviations for modified residues all vary between houses, and a sequence should be unambiguous on its face. See Peptide.

What a quotation reveals

[edit]

A quotation that names a delivery date, a purity grade and a determination set is a more informative document than one giving only a price. It says the supplier has assessed the sequence rather than applied a per-residue rate.[1]

Declining to quote is also informative and is not a negative signal. Some sequences are genuinely difficult, some require capability a given house does not have, and a house that declines rather than accepting and failing is behaving reasonably.

References

  1. ^ a b c Behrendt R, White P, Offer J. "Advances in Fmoc solid-phase peptide synthesis." Journal of Peptide Science 22(1):4–27 (2016). PMID 26785684.
  2. ^ a b United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.